Is calprotectin testing safe during pregnancy?

Curious whether calprotectin testing during pregnancy is safe—and whether it can actually help you understand digestive symptoms? This article explains what fecal calprotectin is, how the test works, what it can and cannot tell you, and where it fits in pregnancy-safe diagnostics. You’ll learn why stool test safety is generally high, how inflammatory marker testing supports prenatal care when gut symptoms arise, and how microbiome insights can add helpful context. If you’re navigating bloating, diarrhea, or abdominal discomfort during pregnancy, this guide offers balanced, evidence-aware information to help you talk with your care team and make informed choices.

Introduction

During pregnancy, the body undergoes sweeping physiological and immunologic changes—many of which touch the digestive tract. It’s common to notice shifts in appetite, bowel habits, and tolerance to foods. For some, symptoms remain mild; for others, gastrointestinal discomfort becomes a recurring concern. Interest in prenatal diagnostics and the maternal microbiome has grown alongside this reality, especially as families look for non-invasive, pregnancy-safe ways to understand symptoms. Within this landscape, fecal calprotectin has emerged as a widely used stool-based inflammatory marker. In this article, we explore the safety and utility of calprotectin testing during pregnancy, how it differs from other tests, and when it can add clarity to questions about gut health, maternal wellness, and fetal development.

Core Explanation of the Topic

What is Calprotectin Testing?

Calprotectin is a protein found inside neutrophils, a type of white blood cell that plays a central role in inflammation. When the lining of the gut becomes inflamed, neutrophils move into the intestinal lumen and release calprotectin, which is then excreted in stool. Measuring fecal calprotectin (often abbreviated “FC”) provides a non-invasive snapshot of intestinal inflammatory activity. While this test does not diagnose a specific disease, it is widely used to help distinguish inflammatory conditions—such as inflammatory bowel disease (IBD: Crohn’s disease and ulcerative colitis)—from non-inflammatory conditions like irritable bowel syndrome (IBS), and to monitor known IBD over time.

Clinically, fecal calprotectin is valued because it is relatively specific to the gut and less influenced by systemic changes elsewhere in the body. Laboratories typically report calprotectin in micrograms per gram (µg/g) of stool. Although cutoffs vary by lab, general interpretive bands often include: low/normal values (commonly under 50 µg/g), borderline or indeterminate ranges (roughly 50–200 µg/g), and elevated levels (over 200 µg/g) suggestive of active intestinal inflammation. Interpretation should always occur in clinical context, because values can be influenced by infection, medication use (for example, NSAIDs), and timing.

Is Calprotectin Testing Safe During Pregnancy?

Yes. Fecal calprotectin testing is a non-invasive stool test that does not involve radiation, contrast agents, or systemic medications, and it poses no known direct risk to the fetus. You collect a small stool sample at home (or in a clinic), and a laboratory analyzes it. Major specialty society guidelines for IBD in pregnancy endorse the use of fecal calprotectin to monitor disease activity during gestation because it helps clinicians estimate intestinal inflammation without relying on imaging or invasive endoscopy unless absolutely necessary.

Because pregnancy can change many blood-based markers (for example, erythrocyte sedimentation rate naturally rises), clinicians often prefer objective tools that are minimally affected by gestational physiology. Fecal calprotectin tends to reflect gut-specific inflammatory activity rather than pregnancy-related systemic shifts. While a few studies suggest trimester-related variation is possible, current evidence and clinical practice support its safety and usefulness as part of prenatal diagnostics when gastrointestinal concerns arise. As always, individual test decisions should be made in partnership with your obstetric and gastrointestinal care teams.

Why This Topic Matters for Gut Health

The Connection Between Gut Inflammation and Pregnancy Outcomes

Gut inflammation can influence appetite, nutrient absorption, hydration status, and energy—all of which matter during pregnancy. In conditions like IBD, the degree of intestinal inflammation often correlates with symptom severity and can affect pregnancy experience. Although many pregnancies progress well even when digestive symptoms occur, uncontrolled intestinal inflammation increases the risk of complications such as malnutrition, anemia, or dehydration, which in turn can affect maternal wellness. In this context, objective inflammatory markers like fecal calprotectin help track the gut’s inflammatory status and inform decisions about further evaluation or supportive care.

Beyond diagnosed IBD, infections or other inflammatory processes can occasionally emerge during pregnancy, compounding normal pregnancy-related changes in bowel habits. Differentiating pregnancy-related discomfort (for example, reflux or constipation due to hormonal changes and iron supplementation) from inflammation-driven symptoms isn’t always straightforward. Calprotectin doesn’t replace clinical judgment, but it supplies a data point that supports safer, more selective use of additional diagnostics.

Potential Risks and Benefits of Diagnostic Testing During Pregnancy

All medical testing in pregnancy involves a benefit-risk consideration. With stool tests like fecal calprotectin, the risk is minimal because there is no exposure to radiation, anesthesia, or invasive procedures. The benefits include an objective, gut-specific signal that can assist with triaging symptoms, prioritizing next steps, and sometimes avoiding unnecessary imaging or endoscopy. Limitations include the possibility of false positives (for example, elevations from a transient infection) and false negatives (levels that are normal even when symptoms persist due to non-inflammatory causes). The best use of calprotectin testing is alongside a clinical exam, medication review, and selective use of other labs such as C-reactive protein (CRP) when indicated.

Related Symptoms, Signals, or Health Implications

Recognizing Signs of Gut Imbalance and Inflammation During Pregnancy

Common digestive symptoms in pregnancy include nausea, vomiting, reflux, constipation, diarrhea, bloating, abdominal cramping, and changes in stool appearance. Many of these are driven by hormonal shifts, slower gastrointestinal motility, and iron supplementation. However, certain patterns suggest checking for inflammation or infection may be helpful:

• Persistent or worsening diarrhea lasting more than a week
• Unexplained abdominal pain, especially if severe or focal
• Rectal bleeding or mucus in stool
• Fever or signs of systemic illness
• Unintentional weight loss or inability to maintain hydration
• History of IBD, celiac disease, or prior significant gut conditions

These signals do not diagnose a condition by themselves, but they can prompt a conversation about whether non-invasive tests—including fecal calprotectin—may help clarify what’s happening. Some individuals also notice fatigue or nutrient-related concerns if absorption is impaired. When symptoms persist, objective testing can reduce guesswork.

Health Implications of Untreated Gut Inflammation

If enteric inflammation is present and goes unchecked, potential consequences include impaired nutrient absorption (especially iron and folate), dehydration, electrolyte imbalance, and reduced quality of life from pain or frequent stools. In the minority of cases with significant inflammation, there can be higher risk of complications, which is why early evaluation and close monitoring during pregnancy are prudent. The aim is not to chase every symptom with testing, but rather to identify when targeted, low-risk diagnostics may uncover an actionable issue. In that framework, stool-based inflammatory markers can provide timely information while avoiding invasive procedures unless clearly indicated.

Individual Variability and Uncertainty

Why Every Pregnancy and Gut Health Profile Is Unique

Human biology is not one-size-fits-all. Genetic differences, prior medical history, medication exposures, diet, stress, sleep patterns, and the make-up of the gut microbiome vary widely among individuals and across trimesters. Pregnancy itself reshapes immune responses and gut motility, which means two people can experience the same week of gestation quite differently. Some pregnant individuals with a history of gut issues breeze through with minimal symptoms; others, previously symptom-free, develop persistent discomfort or intolerance to certain foods. Personalized interpretation of any test—including calprotectin—should account for your unique baseline, your microbiome, and your clinical context.

Limitations of Symptom-Based Guesswork

Symptoms are important, but they’re not always accurate clues to what’s happening biologically. For example, both IBS and IBD can cause cramping and diarrhea; reflux and gallbladder issues can both present with upper abdominal pain; iron supplements can darken stools without signaling inflammation. Solely relying on symptoms can delay appropriate evaluation or lead to unnecessary concern. Objective measures like fecal calprotectin, combined with clinical examination, help clarify whether inflammatory processes are likely, enabling more precise next steps.

Why Symptoms Alone Do Not Reveal the Root Cause

The Complexity of Digestive Disorders in Pregnancy

Pregnancy-related hormonal changes can slow gut transit, increase reflux, and change sensations of fullness. Simultaneously, infections, lactose intolerance, small intestinal bacterial overgrowth (SIBO), celiac disease, bile acid malabsorption, and inflammatory bowel disease can all produce overlapping symptoms. Stress and sleep disruptions add further complexity. Without objective markers, distinguishing functional discomfort from inflammation or infection may be challenging. This is why many clinicians view stool-based inflammatory marker testing as an early, low-risk step when symptoms are persistent or severe.

The Role of Inflammatory Marker Testing

Fecal calprotectin supports pattern recognition. Elevated values suggest neutrophil activity in the gut, prompting clinicians to consider inflammatory or infectious causes and sometimes to add targeted stool cultures, parasite tests, or follow-up imaging. Normal or low values, on the other hand, can steer attention toward non-inflammatory drivers (dietary intolerances, functional bowel disorders, medication effects). In pregnancy, this discriminative value is particularly useful because it can reduce reliance on procedures like endoscopy and CT scanning unless there is a strong indication.

The Role of the Gut Microbiome in This Topic

Understanding the Microbiome’s Influence on Gut Health During Pregnancy

The gut microbiome—trillions of bacteria, viruses, fungi, and other microbes—contributes to digestion, vitamin production, immune training, and maintenance of the gut barrier. During pregnancy, microbiome composition often shifts. Research has observed changes in microbial diversity and increases in certain groups (for example, Proteobacteria and Actinobacteria in late pregnancy) that may reflect the body’s metabolic and immune adaptations. While many of these shifts are normal, imbalances (dysbiosis) can correlate with symptoms like bloating, irregular stools, and food sensitivities. The immune system’s dialogue with gut microbes also influences inflammatory tone, which is why microbiome health is linked to markers like calprotectin.

Microbiome Imbalances and Inflammatory Diseases

Altered microbial communities are associated with an increased likelihood of intestinal inflammation in conditions such as IBD, and some studies have observed correlations between dysbiosis and pregnancy-related complications, though causation is not fully established. Mechanistically, dysbiosis can increase gut permeability (“leaky gut”) and stimulate immune pathways that recruit neutrophils to the intestinal lining—events that can raise fecal calprotectin. Conversely, a balanced microbiome rich in short-chain fatty acid (SCFA) producers may support epithelial integrity and help modulate inflammatory responses. This interplay does not mean the microbiome alone causes or cures disease, but it underscores why understanding microbial balance can be informative when interpreting inflammatory marker testing.

How Microbiome Testing Provides Insight

What a Microbiome Test Can Reveal in Pregnancy-Related Gut Health

Microbiome testing analyzes the composition of microbes in your stool to highlight patterns associated with gut function. While it is not a diagnostic test for disease, it can reveal:

• Overall diversity and community balance, including whether certain beneficial groups are underrepresented
• Relative abundance of microbes linked with SCFA production, bile acid metabolism, and mucosal health
• Signals suggestive of dysbiosis or overgrowth of specific taxa sometimes associated with symptoms
• Context for dietary patterns and tolerances that may support or challenge microbial balance
• Potential correlations with inflammation-related signals that can complement fecal calprotectin interpretation

For expectant parents seeking a clearer picture of their gut ecosystem, an at-home microbiome test can offer educational, personalized insights that support discussions with healthcare professionals. If you are exploring this route, you can learn more about an at-home microbiome testing option designed to help you understand your microbial diversity and potential imbalances.

1-minute gut check Do you often feel bloated, tired or sensitive to foods? Your gut bacteria may be out of balance. ✔ Takes 1 minute ✔ Based on real microbiome data ✔ Personalized result Take the free test →

Complementing Calprotectin Testing with Microbiome Analysis

Calprotectin answers a narrow but essential question: Is there evidence of intestinal inflammation? Microbiome analysis answers a different one: What is the community make-up that may influence gut function and inflammatory tone? Together, they offer a more complete perspective. For example, an elevated fecal calprotectin with signs of dysbiosis may prompt clinicians to look more closely for inflammatory or infectious causes while also addressing contributors to imbalance. Conversely, a normal calprotectin with microbiome features linked to functional symptoms may encourage focus on diet, fiber types, timing of meals, and stress/sleep hygiene while avoiding unnecessary invasive procedures.

If your goal is to understand your gut’s ecosystem in a non-invasive, pregnancy-compatible way, consider reviewing the details of a microbiome testing kit and speaking with your care team about how results might be interpreted thoughtfully during pregnancy.

Who Should Consider Testing During Pregnancy

When Microbiome and Inflammatory Testing Are Recommended

Testing is not mandatory for everyone. It may be reasonable to discuss fecal calprotectin and/or microbiome testing with your clinician if you have:

• Persistent diarrhea, abdominal pain, or rectal bleeding
• Unexplained changes in bowel habits lasting more than a couple of weeks
• Systemic symptoms like fever, fatigue, or unintentional weight loss
• A known history of IBD, celiac disease, or past inflammatory gut issues
• Abnormal inflammatory markers noted on prenatal labs (recognizing pregnancy can affect some markers)
• Prior pregnancy complications thought to be related to gut health or nutrition

These considerations do not replace professional evaluation. Rather, they highlight scenarios where non-invasive tests may add meaningful information to guide safe, pragmatic next steps.

Consulting Healthcare Providers for Personalized Guidance

Collaboration matters. Obstetricians, midwives, family physicians, gastroenterologists, and dietitians can help decide when to use inflammatory marker testing or microbiome analysis and how to interpret results. Your care team also assesses medications that might influence test outcomes (for example, NSAIDs can raise fecal calprotectin; some acid-suppressing medications may modestly affect values). By viewing tests as tools, not verdicts, clinicians can help you navigate the right balance between reassurance, watchful waiting, and focused follow-up.

Decision-Support Section: When Does Testing Make Sense?

Indicators for Pregnant Women to Pursue Gut and Microbiome Diagnostics

Consider asking about fecal calprotectin or microbiome testing if you experience:

• Diarrhea or cramping unresponsive to routine measures (hydration, diet adjustments) over 7–10 days
• Stool changes with mucus or visible blood
• Fever, chills, or signs of infection along with gastrointestinal distress
• Recurrent symptoms affecting eating, sleep, or hydration
• Known IBD and the need for pregnancy-safe monitoring of disease activity
• Ambiguous symptoms where your clinician wants to minimize invasive procedures unless necessary

When symptoms are severe—significant bleeding, intractable vomiting, marked dehydration, or intense abdominal pain—seek immediate medical care. Those situations may require urgent evaluation beyond stool tests.

Safety Considerations for Stool Tests and Diagnostic Procedures During Pregnancy

Stool tests like fecal calprotectin are generally considered safe in pregnancy. Still, discuss the following with your care team:

• Medication review: NSAIDs can elevate calprotectin; acid-suppressing drugs may have modest effects; antibiotics and infections can also influence results.
• Timing and stability: Follow collection instructions closely; some kits include stabilizing buffers to preserve sample integrity.
• Laboratory standards: Choose accredited labs with validated assays and pregnancy-aware interpretation when possible.
• Complementary tests: In some cases, CRP, stool cultures, or parasite panels may be added to refine interpretation.
• Avoiding unnecessary exposure: Use stool-based and ultrasound/MRI-first approaches; reserve endoscopy or CT for when benefits clearly outweigh risks.

Biological Mechanisms: From Inflammation to Markers

Understanding why fecal calprotectin rises helps clarify its role. When the intestinal mucosa is inflamed, epithelial barrier integrity is disrupted. Microbial products and dietary antigens can more easily engage the immune system, recruiting neutrophils to the lamina propria and lumen. Activated neutrophils release calprotectin, which binds calcium and zinc, and serves antimicrobial functions while signaling ongoing inflammation. The result is elevated fecal calprotectin levels that reflect neutrophil-driven activity at the mucosal surface. By contrast, functional bowel disorders without mucosal inflammation generally show low or normal fecal calprotectin, despite significant symptoms. This gut-specific biology is what makes the marker useful in a pregnancy context where many systemic markers are less reliable.

Putting Results in Context: Interpretation Nuances

Interpreting fecal calprotectin during pregnancy relies on context:

• Low/normal values: More consistent with non-inflammatory drivers (functional symptoms, diet effects, medication side effects). May support conservative management.
• Borderline values: Might warrant repeat testing, correlation with other labs (CRP), or evaluation for transient causes, such as recent gastroenteritis.
• Elevated values: Suggest active mucosal inflammation. Your clinician may consider stool cultures, selective imaging, or referral to gastroenterology, balancing pregnancy-safe options.

There is no universal number that diagnoses a specific condition. Individual labs set their own cutoffs, and clinicians weigh your symptoms, history, and exam findings. If you have IBD, your provider may use serial fecal calprotectin measurements to track trends over time, with the goal of maintaining remission throughout pregnancy using therapies known to be compatible with gestation.

The Microbiome-Guided View of Maternal Wellness

Because microbes powerfully shape digestion, immunity, and inflammation, a microbiome-guided approach to maternal wellness emphasizes balance rather than micromanaging one organism. Food variety, fiber types, prebiotic-rich plants, and adequate hydration often support a more resilient microbial community, though specific recommendations should be personalized, especially if symptoms are present. Sleep hygiene, gentle movement as approved by your clinician, and stress management practices may also affect the gut-brain axis. Microbiome testing doesn’t prescribe a cure; it highlights patterns that can inform supportive strategies while your care team prioritizes safety and nutritional adequacy for pregnancy.

How Microbiome and Calprotectin Results Inform Each Other

Consider a few illustrative patterns:

• Elevated calprotectin + dysbiosis: May prompt further evaluation for inflammatory or infectious causes while also addressing diet, fiber type, and other modifiable contributors to imbalance.
• Normal calprotectin + dysbiosis: Points toward non-inflammatory contributors to symptoms; supports lifestyle and nutrition changes without invasive procedures.
• Elevated calprotectin + microbiome rich in pathobionts: Encourages targeted workup for infection or mucosal disease and close coordination between obstetric and GI care.

These are not prescriptions, but conceptual examples of how combining data points refines decision-making in a pregnancy-appropriate, safety-first manner. If you’re curious how a personalized report frames microbial diversity and balance, review the overview of an educational microbiome analysis and discuss with your clinician what any findings might mean for you.

Practical Considerations: Collection, Hygiene, and Communication

Collecting a stool sample during pregnancy raises practical questions. Follow the kit instructions carefully to avoid contamination with urine or toilet water, use the provided tools to sample from multiple areas of a single bowel movement if requested, and seal containers tightly. Wash hands thoroughly and return the sample promptly or store as directed. Good hygiene protects you and your household from potential pathogens present in stool. Inform your provider about recent infections, antibiotic use, or medications (including over-the-counter drugs and supplements), because these factors can influence results. Importantly, sample collection is not known to pose a risk to the fetus.

Common Confounders and How to Address Them

• Recent gastrointestinal infection: Can transiently elevate fecal calprotectin. Retesting after recovery may clarify baseline.
• NSAIDs: Can raise fecal calprotectin; many are avoided in late pregnancy. Ensure your clinician knows what you’re taking.
• Proton pump inhibitors (PPIs): Some data suggest modest effects on fecal calprotectin in certain individuals. Interpret accordingly.
• Rectal bleeding from hemorrhoids: May accompany pregnancy; while it doesn’t directly skew calprotectin, it merits clinical evaluation.
• Lab-to-lab variability: Use the same laboratory when possible for serial monitoring to ensure consistency.

Nutrition, Fiber, and Tolerance During Pregnancy

Fiber supports microbial fermentation and SCFA production, which generally benefits gut barrier function and motility. In pregnancy, however, individual tolerance varies. Some people thrive with higher fiber intake and diverse plants; others experience gas and discomfort if they increase fiber too quickly. Hydration is essential when adjusting fiber. If calprotectin is normal and symptoms seem functional, a gradual, individualized approach to fiber and fermentable foods may help. When calprotectin is elevated, work with your care team to prioritize safety and ensure that nutrition meets pregnancy needs while any inflammatory process is addressed.

Communication with Your Care Team: What to Ask

• Based on my symptoms, do you think a fecal calprotectin test would add useful information?
• If calprotectin is elevated, what pregnancy-compatible next steps would you consider?
• Could my current medications affect the result, and should I time the test accordingly?
• Would microbiome testing be informative in my case, and how would you interpret the results?
• If my results are borderline, how do we decide between repeating the test versus additional workup?

Key Takeaways

• Fecal calprotectin is a non-invasive stool marker that reflects intestinal inflammation by measuring a protein from neutrophils.
• Calprotectin testing is considered safe during pregnancy and is used in clinical practice to help monitor gut inflammation, including in IBD.
• Symptoms alone rarely reveal the root cause; objective markers reduce guesswork and can limit unnecessary invasive procedures.
• Pregnancy changes many systemic labs, but fecal calprotectin remains focused on gut mucosal activity, aiding interpretation.
• The gut microbiome influences inflammation; microbiome testing offers educational insights into microbial balance and diversity.
• Test results must be interpreted in context of medications, recent infections, and clinical history.
• Low-risk diagnostics like stool testing support maternal wellness by guiding timely, appropriate follow-up when needed.
• When used together, calprotectin and microbiome insights can inform personalized, pregnancy-compatible care plans.

Frequently Asked Questions

Is calprotectin testing safe during pregnancy?

Yes. Fecal calprotectin is a stool-based, non-invasive test that does not expose you or your baby to radiation, dyes, or sedation. It’s routinely used in pregnancy to help assess intestinal inflammation when symptoms warrant evaluation.

What does an elevated fecal calprotectin mean while I’m pregnant?

Elevated levels suggest neutrophil-driven inflammation in the gut. Causes include flare of inflammatory bowel disease, infections, or other inflammatory processes. Your clinician will interpret the value alongside your symptoms, history, and possibly additional tests.

Can pregnancy itself raise calprotectin levels?

Most evidence indicates that fecal calprotectin primarily reflects gut mucosal inflammation rather than pregnancy-related systemic changes. Some variability is possible, especially across trimesters, so results are best interpreted by your clinician in context.

Will my medications affect fecal calprotectin results?

They can. NSAIDs may increase fecal calprotectin, and some acid-suppressing medicines may have modest effects. Always provide a complete list of prescription and over-the-counter medications and supplements to your care team before testing.

1-minute gut check Do you often feel bloated, tired or sensitive to foods? Your gut bacteria may be out of balance. ✔ Takes 1 minute ✔ Based on real microbiome data ✔ Personalized result Take the free test →

Is a stool test better than blood tests during pregnancy?

They serve different purposes. Blood tests like CRP can reflect systemic inflammation but may be influenced by pregnancy physiology. Fecal calprotectin is gut-focused. Clinicians often use both, along with symptom assessment, to form a clearer picture.

Can I use calprotectin testing to diagnose IBS or IBD in pregnancy?

No single test can diagnose IBS or IBD. Calprotectin helps distinguish inflammatory from non-inflammatory processes, guiding whether further workup is needed. A diagnosis relies on a combination of clinical evaluation, tests, and sometimes imaging or endoscopy.

How is a stool sample collected for calprotectin testing?

You’ll use a kit with instructions to collect a small sample at home or in a clinic. Avoid contamination, seal the container properly, and return or store the sample as directed to maintain stability and accuracy.

What if my calprotectin is borderline?

A borderline result may prompt repeat testing after a short interval, especially if you recently had an infection. Your clinician may also check other markers or consider your symptoms and history to decide on the next steps.

How does microbiome testing fit into pregnancy care?

Microbiome testing is an educational tool that characterizes microbial composition and balance. It does not diagnose disease, but it can contextualize symptoms, inform dietary discussions, and complement inflammatory markers like calprotectin.

Can a normal calprotectin mean my symptoms are “all in my head”?

No. Many real and distressing gastrointestinal symptoms occur without mucosal inflammation. A normal calprotectin suggests looking at non-inflammatory drivers such as diet, motility, microbiome balance, stress, or medication effects.

Is endoscopy safe during pregnancy if my calprotectin is high?

Endoscopy can be performed during pregnancy when clearly indicated, with attention to timing, sedation choices, and fetal monitoring. However, non-invasive tests like fecal calprotectin help ensure procedures are reserved for situations where benefits outweigh risks.

Where can I learn more about non-invasive microbiome insights?

To understand what an at-home microbiome analysis can reveal about microbial diversity and balance, you can review this overview of a microbiome test. Discuss with your clinician how any findings could be interpreted during pregnancy.

Conclusion

Fecal calprotectin offers a pregnancy-compatible window into intestinal inflammation. It is safe, non-invasive, and clinically useful for clarifying whether persistent gastrointestinal symptoms may involve mucosal inflammation. Yet it is only one piece of the puzzle. Because every pregnancy and microbiome is unique, combining calprotectin with thoughtful clinical evaluation—and, when appropriate, microbiome insights—can reduce uncertainty, avoid unnecessary procedures, and support maternal wellness. By focusing on objective data, open communication with your care team, and personalized strategies, you can navigate digestive symptoms in pregnancy with clarity and confidence.

Keywords

calprotectin testing during pregnancy, pregnancy health, stool test safety, prenatal diagnostics, inflammatory marker testing, maternal wellness, fecal calprotectin, gut microbiome, microbiome testing, intestinal inflammation, IBD in pregnancy, IBS vs IBD, non-invasive testing, dysbiosis, gut health in pregnancy, CRP, stool biomarkers, maternal gut health, personalized gut health, microbial diversity